Patent Assignment
Reel/Frame 031494/0933
Release of Lien on Patents
Recorded: 2013-10-24
Pages: 4
Assignor
BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Executed: 2013-10-04
Assignee
APTALIS PHARMA CANADA INC.
597 BOULEVARD SIR-WILFRID-LAURIER, MONT-SAINT-HILAIRE, QUEBEC, CANADA
Covered Properties
(2)
Stable Aqueous Suspensions of Mesalazine
Patent:
5,731,302 →
Application:
08/722,720 →
Double Capsule for the Administration of Active Principles in Multiple Therapies
Patent:
6,350,468 →
Application:
09/581,721 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement
Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release
Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Change of Name
Mar 18, 2016
From: APTALIS PHARMA CANADA INC.
To: APTALIS PHARMA CANADA ULC
Reel/Frame 038037/0424 →